生物模拟纳米药物通过细胞外细胞分解制备,通过减弱Wnt信号通路诱导癌症干细胞分化
Juncai Zhang1, Jinchao Zhang1, Leyao Kang1
1State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Laboratory of Chemical Biology of Hebei Province & College of Chemistry and Materials Science, Hebei University, Baoding, 071002, P. R. China.
Advanced healthcare materials
|June 4, 2025
概括
这项研究开发了一种新型纳米药物,使用带有西斯丁的介质干细胞衍生外体. 这种方法有效地向癌症干细胞,促进它们分化为成熟细胞以提高化疗敏感性.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 纳米技术纳米技术
背景情况:
- 癌症干细胞 (CSCs) 驱动化学抵抗和瘤复发,使它们成为关键的治疗点.
- 目前的CSC分化疗法面临的挑战是对正常干细胞的特异性和非向性影响.
- 介质干细胞衍生的外体细胞 (MSC-exos) 显示出作为向药物载体的前景,因为它们能够修改CSC功能.
研究的目的:
- 开发和评估用于CSC向差异化治疗的基于外体的局部生物合成纳米药物.
- 研究纳米药物诱导CSC分化并增强化学敏感性的机制.
- 评估新型纳米药物方法的疗效和安全性.
主要方法:
- 通过将MSC与含药纳米颗粒化,在现场生物合成含西斯的MSC-exos (E-DDP@MSNs).
- 通过超离心隔离E-DDP@MSN的隔离,保持外体含量.
- 评估CSC分化诱导,Wnt通路衰减和化学敏感性增强.
主要成果:
- E-DDP@MSNs有效地促进了CSC分化成成熟的瘤细胞,增加了它们对化疗的敏感性.
- 纳米药物机制涉及到外体DKK-1的输送,导致Wnt通路衰减.
- 与电穿孔相比,E-DDP@MSNs显示出对外体含量和疗效的优越保留.
结论:
- E-DDP@MSNs代表了针对CSC的差异化治疗的有希望的策略.
- 这种方法提供了高疗效与潜在的最小毒性.
- 该研究强调了MSC-exos作为癌症治疗药物载体的潜力.
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
01:41Non-Canonical Wnt Signaling Pathways
8.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
02:54Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K